AU Stock MarketDetailed Quotes

Australian Clinical Labs Ltd (ACL)

Watchlist

1.920
+0.030+1.59%

20min DelayMarket Closed May 1 16:00 AET

360.33MMarket Cap11.23P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Australian Clinical Labs Ltd (ACL) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2025

(FY)Jun 30, 2024

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

Operating cash flow (direct method)

Cash income from operating activities

5.68%734.17M

-3.35%694.68M

-27.42%718.73M

49.59%990.24M

661.97M

Revenue from customers

5.68%734.17M

-3.35%694.68M

-27.42%718.73M

49.59%990.24M

--661.97M

Cash paid

-1.99%-518.88M

6.39%-508.76M

13.17%-543.47M

-39.03%-625.93M

-450.22M

Payments to suppliers for goods and services

-1.99%-518.88M

6.39%-508.76M

13.17%-543.47M

-39.03%-625.93M

---450.22M

Direct interest paid

-10.74%-18.46M

-20.41%-16.67M

-21.55%-13.85M

71.08%-11.39M

---39.39M

Direct interest received

-18.16%410K

175.27%501K

304.44%182K

-40.00%45K

--75K

Direct tax refund paid

-42.05%-14.43M

43.29%-10.16M

74.00%-17.91M

-271.00%-68.87M

---18.56M

Operating cash flow

14.54%182.8M

11.07%159.59M

-49.42%143.68M

84.64%284.09M

--153.86M

Investing cash flow

Cash flow from continuing investing activities

-22.74%-8.9M

40.51%-7.25M

83.09%-12.18M

-1,085.70%-72.04M

-6.08M

Net PPE purchase and sale

-34.50%-8.31M

7.73%-6.18M

68.07%-6.7M

-123.32%-20.98M

---9.39M

Net business purchase and sale

45.36%-583K

---1.07M

----

Net investment purchase and sale

----

--1.07M

Net other investing changes

----

89.26%-5.48M

-2,367.50%-51.06M

--2.25M

Cash from discontinued investing activities

Investing cash flow

-22.74%-8.9M

40.51%-7.25M

83.09%-12.18M

-1,085.70%-72.04M

---6.08M

Financing cash flow

Cash flow from continuing financing activities

-22.31%-178.74M

-5.99%-146.14M

37.59%-137.88M

-49.90%-220.91M

-147.37M

Net issuance payments of debt

-18.18%-13M

-116.67%-11M

166.00%66M

-292.27%-100M

--52.01M

Net common stock issuance

-997.59%-19.12M

-95.51%-1.74M

81.98%-891K

-103.38%-4.94M

--146.25M

Cash dividends paid

-22.66%-24.95M

79.01%-20.34M

-299.03%-96.88M

42.19%-24.28M

---42M

Net other financing activities

46.19%-121.68M

-6.55%-226.12M

-15.73%-212.21M

51.59%-183.37M

---378.77M

Cash from discontinued financing activities

Financing cash flow

-22.31%-178.74M

-5.99%-146.14M

37.59%-137.88M

-49.90%-220.91M

---147.37M

Net cash flow

Beginning cash position

30.97%26.14M

-24.33%19.96M

-25.15%26.37M

1.10%35.23M

--34.85M

Current changes in cash

-177.92%-4.84M

197.32%6.21M

28.07%-6.38M

-2,221.05%-8.87M

--418K

Effect of exchange rate changes

668.00%142K

37.50%-25K

-900.00%-40K

114.71%5K

---34K

End cash Position

-17.96%21.44M

30.97%26.14M

-24.33%19.96M

-25.15%26.37M

--35.23M

Free cash from

13.92%174.39M

11.95%153.09M

-47.97%136.75M

82.07%262.84M

--144.36M

Accounting Standards

US-GAAP

	(FY)Jun 30, 2025	(FY)Jun 30, 2024	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021
Operating cash flow (direct method)
Cash income from operating activities	5.68%734.17M	-3.35%694.68M	-27.42%718.73M	49.59%990.24M	661.97M
Revenue from customers	5.68%734.17M	-3.35%694.68M	-27.42%718.73M	49.59%990.24M	--661.97M
Cash paid	-1.99%-518.88M	6.39%-508.76M	13.17%-543.47M	-39.03%-625.93M	-450.22M
Payments to suppliers for goods and services	-1.99%-518.88M	6.39%-508.76M	13.17%-543.47M	-39.03%-625.93M	---450.22M
Direct interest paid	-10.74%-18.46M	-20.41%-16.67M	-21.55%-13.85M	71.08%-11.39M	---39.39M
Direct interest received	-18.16%410K	175.27%501K	304.44%182K	-40.00%45K	--75K
Direct tax refund paid	-42.05%-14.43M	43.29%-10.16M	74.00%-17.91M	-271.00%-68.87M	---18.56M
Operating cash flow	14.54%182.8M	11.07%159.59M	-49.42%143.68M	84.64%284.09M	--153.86M
Investing cash flow
Cash flow from continuing investing activities	-22.74%-8.9M	40.51%-7.25M	83.09%-12.18M	-1,085.70%-72.04M	-6.08M
Net PPE purchase and sale	-34.50%-8.31M	7.73%-6.18M	68.07%-6.7M	-123.32%-20.98M	---9.39M
Net business purchase and sale	45.36%-583K	---1.07M	----	----	----
Net investment purchase and sale	----	----	----	----	--1.07M
Net other investing changes	----	----	89.26%-5.48M	-2,367.50%-51.06M	--2.25M
Cash from discontinued investing activities
Investing cash flow	-22.74%-8.9M	40.51%-7.25M	83.09%-12.18M	-1,085.70%-72.04M	---6.08M
Financing cash flow
Cash flow from continuing financing activities	-22.31%-178.74M	-5.99%-146.14M	37.59%-137.88M	-49.90%-220.91M	-147.37M
Net issuance payments of debt	-18.18%-13M	-116.67%-11M	166.00%66M	-292.27%-100M	--52.01M
Net common stock issuance	-997.59%-19.12M	-95.51%-1.74M	81.98%-891K	-103.38%-4.94M	--146.25M
Cash dividends paid	-22.66%-24.95M	79.01%-20.34M	-299.03%-96.88M	42.19%-24.28M	---42M
Net other financing activities	46.19%-121.68M	-6.55%-226.12M	-15.73%-212.21M	51.59%-183.37M	---378.77M
Cash from discontinued financing activities
Financing cash flow	-22.31%-178.74M	-5.99%-146.14M	37.59%-137.88M	-49.90%-220.91M	---147.37M
Net cash flow
Beginning cash position	30.97%26.14M	-24.33%19.96M	-25.15%26.37M	1.10%35.23M	--34.85M
Current changes in cash	-177.92%-4.84M	197.32%6.21M	28.07%-6.38M	-2,221.05%-8.87M	--418K
Effect of exchange rate changes	668.00%142K	37.50%-25K	-900.00%-40K	114.71%5K	---34K
End cash Position	-17.96%21.44M	30.97%26.14M	-24.33%19.96M	-25.15%26.37M	--35.23M
Free cash from	13.92%174.39M	11.95%153.09M	-47.97%136.75M	82.07%262.84M	--144.36M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Middle East conflict spreads to the stock market! How should investors respond?

On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm